Novogene America Showcases Cutting-Edge Sequencing Solutions at AACR 2025

Chicago, IL – April 25–30, 2025 – Novogene America proudly exhibited at the American Association for Cancer Research (AACR) Annual Meeting 2025, held at the McCormick Place Convention Center in Chicago, Illinois. As one of the largest gatherings in the oncology research community, AACR 2025 welcomed over 20,000 scientists, clinicians, and industry professionals from around the globe to explore the latest breakthroughs in cancer research and treatment.

At Booth #2721, the Novogene team, including sales representatives, sequencing specialists, and product managers, engaged in dynamic, in-depth discussions with attendees about their sequencing projects and research goals. These conversations highlighted Novogene’s commitment to providing tailored, high-quality solutions that meet the evolving needs of the scientific community.

To celebrate the occasion, Novogene offered an exclusive 15% discount on services for AACR attendees. The company also spotlighted its 10X Single Cell Spatial RNA Sequencing service, a powerful tool for spatially resolved transcriptomics that enables researchers to gain deeper insights into tissue architecture and cellular heterogeneity in cancer and other complex diseases.

About Novogene

Novogene is a global leader in Next-Generation Sequencing (NGS), Proteomics, and Metabolomics services, empowering researchers and organizations with cutting-edge multi-omics solutions. Since our founding in March 2011, we have remained at the forefront of innovation, delivering world-class services to advance discoveries in life sciences, healthcare, and beyond.

At Novogene, we have built a highly skilled, interdisciplinary team, with the majority holding advanced degrees from top global institutions. Our high-throughput sequencing and high-performance computing platforms are designed to efficiently handle large-scale genomic data, meeting the evolving demands of life sciences and medical research with secure data storage and powerful bioinformatics analysis.

Through extensive collaborations with leading academic institutions, hospitals, pharmaceutical companies, and agricultural enterprises, Novogene continues to shape the future of genomic research and precision medicine. As a trusted genomics partner, we are committed to empowering researchers worldwide with the technology, expertise, and solutions needed to advance genomics and improve life.